Correlation of insulin resistance with dyslipidemia and liver enzymes in lean non-alcoholic fatty liver disease: A case–control study in a tertiary care hospital
DOI:
https://doi.org/10.71152/ajms.v16i9.4707Keywords:
Lean non-alcoholic fatty liver disease; Insulin resistance; Dyslipidemia; Liver enzymes; Case–control study; Tertiary care hospitalAbstract
Background: Non-alcoholic fatty liver disease (NAFLD) is a widespread hepatic condition with excessive fat accumulation in the liver without alcohol consumption. Conventionally, NAFLD is linked with obesity, although lean individuals can also develop it with significant metabolic changes.
Aims and Objectives: The purpose of our study is to investigate the correlation between insulin resistance (IR), dyslipidemia, and liver enzyme levels in lean NAFLD patients compared to age/sex-matched healthy controls.
Materials and Methods: The current case–control study was conducted at a tertiary care hospital, comprising lean NAFLD patients (body mass index [BMI] <23 kg/m2) and age and sex-matched healthy controls. Fasting blood sugar (FBS) and homeostatic model assessment of IR (HOMA-IR) were used to assess the IR. Lipid profiles: Total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c) were determined as per standard assay protocol. Other parametric analyses done were liver enzymes: Alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and gamma-glutamyl transferase (GGT). Statistical analyses were performed to determine the significance of differences between groups.
Results: Lean NAFLD group showed elevated FBS, serum insulin, and HOMA-IR levels compared to obese NAFLD patients and healthy controls with a significant statistical disparity. The lean NAFLD patients had significantly lower waist circumference and systolic blood pressure when compared to obese NAFLD patients, indicating that the visceral adipose tissues of lean NAFLD may be metabolically more active conferring metabolic risk to NAFLD. No statistically significant correlation was documented between HOMA-IR and HDL-C, LDL-C, ALT, AST, and GGT.
Conclusion: This study reveals significant metabolic and biochemical disparity among lean NAFLD, obese NAFLD, and control group. Lean NAFLD patients exhibit pronounced IR, despite having lower BMI as compared to obese. Moreover, lean NAFLD patients show substantial liver dysfunction, marked by higher levels of ALT, AST, and GGT.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Asian Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
